86exporter.com Home       Products Catalog      Suppliers Catalog      Log In        Sign up
      About Us
      Profile
      Products
      Contact Us


Wuhan Newbio Pharm-tech Co., Ltd.

Products >> Raw Material Bortezomib with Good Price (CAS# 1793

Raw Material Bortezomib with Good Price (CAS# 1793

Build Your Online Product Catalogs?



Description
Product Name: Raw Material Bortezomib with Good Price (CAS# 1793
Supply Ability: 100g
Related proudcts api, pharmaceutical, intermediate,
Specifications medicine grade
Price Term: FOB,CNF,CIF
Port of loading: Shenzhen
Minimum Order 100
Unit Price: 2.5

High Quality Bortezomib with Good Price
(CAS179324-69-7)

Chemical Information:
Product Name: Bortezomib
Other Name:VELCADE;dpba;BORTEZOMIB;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;VELCADE(BORTEZOMIB);Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Bortezomib for research;Bortezomib ( Velcade, MG-341, PS-341 )
Model No.: ATC-169
CAS No.: 179324-69-7
Molecular Formula: C19H25BN4O4
Molecular Weight: 384.24
Appearance: Yellow Solid
Purity: 99%+
Product Specifications: Pharmaceutical Grade 
Standard: Qualified
MOQ(Minimum Order Quantity): 10g
Payment: L/C, T/T, Western Union
Shipment: EMS, DHL, FedEx
Packing: Aluminium Foil Bag or as Required    
Origion: Hubei,China  
Export Markets: Global   

         
Product Description:
Bortezomib CAS :179324-69-7 Brand:NEWBIO
MW:C19H25BN4O4 MSDS: Avaiable
MF :384.2372 Sample: Avaiable
Category: Oncology drug Min order: 10grams
Quality standard:USP Place of Origin:China
Introduction is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease.
Character White or almost white powder
Applications Pharmaceutical raw materials , Oncology drug
Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle foun d in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.

Usage:
selective proteasome inhibitor

COA:
Item Specification Results
Description White or off-white crystalline powder white powder
Solubility  Very soluble in DMSO or ethanol, 
up to about 200 mg/mL; 
poorly soluble in aqueous solution

Contact Us
Company: Wuhan Newbio Pharm-tech Co., Ltd.
Contact: Mr. Jason Edwards
Address: 858, East Lake, High-Tech Development Zone, Wuhan, Hubei, China
Postcode: 430075
Tel: +86-027-87002705
Fax: 86-27-87050469
E-mail:         


Copyright© Wuhan Newbio Pharm-tech Co., Ltd. All Rights Reserved.
Tel : +86-027-87002705 Fax : 86-27-87050469
Powered by 86exporter.com